Concepts (202)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Breast Neoplasms | 14 | 2025 | 2582 | 3.340 |
Why?
|
| Breast | 3 | 2021 | 208 | 1.610 |
Why?
|
| Biopsy, Large-Core Needle | 5 | 2025 | 34 | 1.470 |
Why?
|
| Fibrocystic Breast Disease | 2 | 2025 | 7 | 1.460 |
Why?
|
| Apocrine Glands | 2 | 2025 | 5 | 1.450 |
Why?
|
| Papilloma, Intraductal | 2 | 2024 | 5 | 1.440 |
Why?
|
| Carcinoma, Lobular | 2 | 2020 | 25 | 1.280 |
Why?
|
| Carcinoma, Ductal, Breast | 2 | 2020 | 85 | 1.230 |
Why?
|
| Lymph Nodes | 2 | 2022 | 373 | 1.160 |
Why?
|
| Carcinoma | 4 | 2019 | 279 | 1.070 |
Why?
|
| Biomarkers, Tumor | 7 | 2021 | 1560 | 0.980 |
Why?
|
| Sentinel Lymph Node Biopsy | 2 | 2021 | 67 | 0.870 |
Why?
|
| Triple Negative Breast Neoplasms | 3 | 2025 | 267 | 0.850 |
Why?
|
| Pregnancy Complications, Neoplastic | 2 | 2021 | 61 | 0.820 |
Why?
|
| Sentinel Lymph Node | 1 | 2021 | 9 | 0.730 |
Why?
|
| Cervix Uteri | 1 | 2022 | 60 | 0.720 |
Why?
|
| Pathologists | 1 | 2021 | 26 | 0.720 |
Why?
|
| Carcinoma, Acinar Cell | 1 | 2021 | 6 | 0.700 |
Why?
|
| Placenta | 2 | 2022 | 511 | 0.670 |
Why?
|
| CDX2 Transcription Factor | 1 | 2020 | 11 | 0.670 |
Why?
|
| Breast Carcinoma In Situ | 1 | 2020 | 2 | 0.660 |
Why?
|
| Matrix Attachment Region Binding Proteins | 1 | 2020 | 19 | 0.660 |
Why?
|
| Carcinoma in Situ | 1 | 2020 | 72 | 0.630 |
Why?
|
| Carcinoma, Intraductal, Noninfiltrating | 1 | 2020 | 68 | 0.630 |
Why?
|
| Axilla | 1 | 2019 | 42 | 0.610 |
Why?
|
| Immunohistochemistry | 5 | 2023 | 1597 | 0.600 |
Why?
|
| Nevus | 1 | 2019 | 34 | 0.600 |
Why?
|
| Neoplasms, Muscle Tissue | 1 | 2019 | 10 | 0.600 |
Why?
|
| Skin Neoplasms | 2 | 2023 | 880 | 0.590 |
Why?
|
| Tracheal Neoplasms | 1 | 2018 | 20 | 0.580 |
Why?
|
| Gastrointestinal Tract | 1 | 2020 | 218 | 0.560 |
Why?
|
| Oncogene Proteins | 1 | 2018 | 133 | 0.550 |
Why?
|
| Melanoma | 1 | 2023 | 898 | 0.510 |
Why?
|
| Lung Neoplasms | 2 | 2018 | 1493 | 0.500 |
Why?
|
| Chromosomes, Human, Pair 14 | 2 | 2013 | 96 | 0.490 |
Why?
|
| Female | 27 | 2025 | 68330 | 0.490 |
Why?
|
| Liver | 1 | 2022 | 1765 | 0.440 |
Why?
|
| Fibroma | 1 | 2014 | 29 | 0.430 |
Why?
|
| Ossification, Heterotopic | 1 | 2014 | 37 | 0.430 |
Why?
|
| Paired Box Transcription Factors | 1 | 2014 | 75 | 0.430 |
Why?
|
| CD5 Antigens | 1 | 2014 | 33 | 0.430 |
Why?
|
| Proto-Oncogene Proteins c-kit | 1 | 2014 | 63 | 0.420 |
Why?
|
| Thymus Neoplasms | 1 | 2014 | 38 | 0.420 |
Why?
|
| Mammary Glands, Human | 1 | 2014 | 80 | 0.410 |
Why?
|
| Precancerous Conditions | 1 | 2016 | 278 | 0.410 |
Why?
|
| Chromosomes, Human, Pair 8 | 1 | 2013 | 78 | 0.400 |
Why?
|
| Hemangioendothelioma, Epithelioid | 1 | 2013 | 10 | 0.400 |
Why?
|
| Humans | 33 | 2025 | 126753 | 0.400 |
Why?
|
| Middle Aged | 13 | 2025 | 27697 | 0.390 |
Why?
|
| Loss of Heterozygosity | 1 | 2013 | 122 | 0.390 |
Why?
|
| Nuclear Proteins | 1 | 2018 | 1204 | 0.370 |
Why?
|
| Microsatellite Repeats | 1 | 2013 | 229 | 0.370 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2013 | 167 | 0.360 |
Why?
|
| Diagnosis, Differential | 5 | 2020 | 1861 | 0.360 |
Why?
|
| Mammography | 2 | 2025 | 129 | 0.360 |
Why?
|
| Meningioma | 1 | 2013 | 110 | 0.350 |
Why?
|
| Translocation, Genetic | 1 | 2013 | 348 | 0.350 |
Why?
|
| Meningeal Neoplasms | 1 | 2013 | 175 | 0.340 |
Why?
|
| Transcription Factors | 1 | 2020 | 2337 | 0.340 |
Why?
|
| Spinal Cord Neoplasms | 1 | 2011 | 63 | 0.330 |
Why?
|
| Anemia | 1 | 2013 | 338 | 0.300 |
Why?
|
| Aged | 7 | 2025 | 20344 | 0.290 |
Why?
|
| Biopsy | 3 | 2020 | 1236 | 0.270 |
Why?
|
| Adult | 7 | 2025 | 30410 | 0.240 |
Why?
|
| Neoplasm Proteins | 2 | 2021 | 652 | 0.240 |
Why?
|
| Follow-Up Studies | 2 | 2025 | 5114 | 0.230 |
Why?
|
| India | 5 | 2013 | 228 | 0.230 |
Why?
|
| Mastectomy | 2 | 2021 | 74 | 0.210 |
Why?
|
| Leiomyoma | 1 | 2024 | 73 | 0.200 |
Why?
|
| Uterine Neoplasms | 1 | 2024 | 103 | 0.190 |
Why?
|
| Pathology Department, Hospital | 1 | 2021 | 1 | 0.180 |
Why?
|
| Proteogenomics | 1 | 2023 | 107 | 0.180 |
Why?
|
| Brain Neoplasms | 1 | 2011 | 1224 | 0.180 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2024 | 234 | 0.180 |
Why?
|
| Pelvis | 1 | 2022 | 69 | 0.180 |
Why?
|
| Anoctamin-1 | 1 | 2021 | 3 | 0.180 |
Why?
|
| Proto-Oncogene Proteins c-ret | 1 | 2021 | 38 | 0.170 |
Why?
|
| GATA3 Transcription Factor | 1 | 2021 | 41 | 0.170 |
Why?
|
| Tumor Microenvironment | 1 | 2025 | 628 | 0.170 |
Why?
|
| Canada | 1 | 2021 | 315 | 0.170 |
Why?
|
| Embryonic Development | 1 | 2022 | 211 | 0.170 |
Why?
|
| Crystal Arthropathies | 1 | 2020 | 4 | 0.170 |
Why?
|
| Synovial Membrane | 1 | 2020 | 26 | 0.160 |
Why?
|
| Pregnancy | 3 | 2022 | 7373 | 0.160 |
Why?
|
| Lymphatic Metastasis | 1 | 2021 | 424 | 0.160 |
Why?
|
| Muscle Neoplasms | 1 | 2020 | 22 | 0.160 |
Why?
|
| Neoplasm Micrometastasis | 1 | 2019 | 13 | 0.160 |
Why?
|
| Academic Medical Centers | 1 | 2021 | 318 | 0.160 |
Why?
|
| Kidney Neoplasms | 1 | 2024 | 437 | 0.160 |
Why?
|
| Ultrasonography, Mammary | 1 | 2019 | 31 | 0.150 |
Why?
|
| DNA Mutational Analysis | 1 | 2021 | 781 | 0.150 |
Why?
|
| Neoadjuvant Therapy | 1 | 2021 | 379 | 0.150 |
Why?
|
| Exophthalmos | 1 | 2018 | 30 | 0.140 |
Why?
|
| Neoplasm Metastasis | 1 | 2020 | 686 | 0.140 |
Why?
|
| Ultrasonography, Interventional | 1 | 2019 | 199 | 0.140 |
Why?
|
| Orbital Neoplasms | 1 | 2018 | 45 | 0.140 |
Why?
|
| Infant, Newborn | 4 | 2022 | 8347 | 0.130 |
Why?
|
| Orbit | 1 | 2018 | 79 | 0.130 |
Why?
|
| Gout | 1 | 2020 | 170 | 0.130 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2021 | 726 | 0.130 |
Why?
|
| Bacteria | 1 | 2020 | 502 | 0.130 |
Why?
|
| Vision Disorders | 1 | 2018 | 188 | 0.120 |
Why?
|
| Rotavirus Infections | 2 | 2008 | 278 | 0.120 |
Why?
|
| Gastroenteritis | 2 | 2008 | 307 | 0.120 |
Why?
|
| Diagnostic Errors | 1 | 2019 | 329 | 0.120 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2021 | 899 | 0.120 |
Why?
|
| Metaplasia | 1 | 2016 | 213 | 0.120 |
Why?
|
| Bone Neoplasms | 1 | 2020 | 428 | 0.120 |
Why?
|
| Cell Movement | 1 | 2019 | 849 | 0.120 |
Why?
|
| Membrane Transport Proteins | 1 | 2016 | 176 | 0.120 |
Why?
|
| Aged, 80 and over | 2 | 2018 | 6668 | 0.120 |
Why?
|
| Microbiota | 1 | 2020 | 426 | 0.110 |
Why?
|
| Rhabdomyosarcoma | 1 | 2018 | 208 | 0.110 |
Why?
|
| Mucinoses | 1 | 2014 | 2 | 0.110 |
Why?
|
| Mitochondrial Turnover | 1 | 2014 | 3 | 0.110 |
Why?
|
| Fibroadenoma | 1 | 2014 | 9 | 0.110 |
Why?
|
| Enzyme Activators | 1 | 2014 | 11 | 0.110 |
Why?
|
| PAX8 Transcription Factor | 1 | 2014 | 14 | 0.110 |
Why?
|
| Glycoproteins | 1 | 2016 | 333 | 0.110 |
Why?
|
| Heterocyclic Compounds, 4 or More Rings | 1 | 2014 | 34 | 0.110 |
Why?
|
| Ultrasonography | 1 | 2019 | 933 | 0.110 |
Why?
|
| Young Adult | 2 | 2018 | 9665 | 0.110 |
Why?
|
| Sirtuin 1 | 1 | 2014 | 56 | 0.110 |
Why?
|
| Male | 9 | 2020 | 62543 | 0.100 |
Why?
|
| Cross Reactions | 1 | 2014 | 180 | 0.100 |
Why?
|
| Retrospective Studies | 3 | 2025 | 17005 | 0.100 |
Why?
|
| Reperfusion Injury | 1 | 2014 | 108 | 0.100 |
Why?
|
| Chromosomes, Human, Pair 10 | 1 | 2013 | 65 | 0.100 |
Why?
|
| Chromosomes, Human, Pair 22 | 1 | 2013 | 97 | 0.100 |
Why?
|
| Surveys and Questionnaires | 2 | 2021 | 3907 | 0.100 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2021 | 2746 | 0.090 |
Why?
|
| Adolescent | 3 | 2018 | 20002 | 0.090 |
Why?
|
| Carrier Proteins | 1 | 2016 | 1011 | 0.090 |
Why?
|
| Bone Marrow | 1 | 2013 | 309 | 0.090 |
Why?
|
| Nerve Sheath Neoplasms | 1 | 2011 | 19 | 0.090 |
Why?
|
| Chromosomes, Human, Pair 17 | 1 | 2013 | 362 | 0.090 |
Why?
|
| Craniopharyngioma | 1 | 2011 | 33 | 0.080 |
Why?
|
| Hospitals | 2 | 2011 | 428 | 0.080 |
Why?
|
| Astrocytoma | 1 | 2011 | 95 | 0.080 |
Why?
|
| Age Distribution | 1 | 2011 | 422 | 0.080 |
Why?
|
| Kidney Diseases | 1 | 2014 | 481 | 0.080 |
Why?
|
| Ependymoma | 1 | 2011 | 139 | 0.080 |
Why?
|
| Diarrhea | 2 | 2008 | 306 | 0.080 |
Why?
|
| United States | 2 | 2021 | 11310 | 0.070 |
Why?
|
| Nurseries, Hospital | 1 | 2008 | 6 | 0.070 |
Why?
|
| Diarrhea, Infantile | 1 | 2008 | 31 | 0.070 |
Why?
|
| Kidney | 1 | 2014 | 1283 | 0.070 |
Why?
|
| Cryptosporidiosis | 1 | 2007 | 35 | 0.070 |
Why?
|
| Medulloblastoma | 1 | 2011 | 378 | 0.070 |
Why?
|
| AIDS-Related Opportunistic Infections | 1 | 2007 | 130 | 0.060 |
Why?
|
| Cell Differentiation | 1 | 2014 | 1842 | 0.060 |
Why?
|
| Infant, Premature, Diseases | 1 | 2008 | 240 | 0.060 |
Why?
|
| Cost of Illness | 1 | 2008 | 283 | 0.060 |
Why?
|
| Rotavirus | 1 | 2008 | 363 | 0.060 |
Why?
|
| Health Care Costs | 1 | 2008 | 392 | 0.050 |
Why?
|
| Prognosis | 1 | 2013 | 4772 | 0.050 |
Why?
|
| NFI Transcription Factors | 1 | 2023 | 50 | 0.050 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2023 | 87 | 0.050 |
Why?
|
| Neurofibromin 1 | 1 | 2023 | 49 | 0.050 |
Why?
|
| Nephrectomy | 1 | 2024 | 172 | 0.050 |
Why?
|
| Hysterectomy | 1 | 2024 | 203 | 0.050 |
Why?
|
| Child | 2 | 2013 | 25101 | 0.040 |
Why?
|
| Macrophages | 1 | 2025 | 640 | 0.040 |
Why?
|
| Receptors, Estrogen | 1 | 2023 | 714 | 0.040 |
Why?
|
| Symptom Assessment | 1 | 2020 | 108 | 0.040 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2021 | 748 | 0.040 |
Why?
|
| Incidental Findings | 1 | 2020 | 121 | 0.040 |
Why?
|
| Hospitalization | 1 | 2008 | 1874 | 0.040 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2023 | 576 | 0.040 |
Why?
|
| Treatment Outcome | 1 | 2014 | 12546 | 0.040 |
Why?
|
| Transcriptome | 1 | 2025 | 1052 | 0.040 |
Why?
|
| Infant | 2 | 2011 | 12771 | 0.040 |
Why?
|
| Infant, Very Low Birth Weight | 1 | 2019 | 161 | 0.040 |
Why?
|
| Fundus Oculi | 1 | 2018 | 30 | 0.030 |
Why?
|
| Fluorescein Angiography | 1 | 2018 | 62 | 0.030 |
Why?
|
| Child, Preschool | 2 | 2011 | 14347 | 0.030 |
Why?
|
| RNA, Messenger | 1 | 2023 | 2537 | 0.030 |
Why?
|
| T-Lymphocytes | 1 | 2025 | 1705 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2020 | 1398 | 0.030 |
Why?
|
| Cesarean Section | 1 | 2019 | 422 | 0.030 |
Why?
|
| Endoscopy | 1 | 2018 | 280 | 0.030 |
Why?
|
| Retina | 1 | 2018 | 445 | 0.030 |
Why?
|
| Tomography, Optical Coherence | 1 | 2018 | 440 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 2014 | 577 | 0.020 |
Why?
|
| Inflammation Mediators | 1 | 2014 | 222 | 0.020 |
Why?
|
| Disease Progression | 1 | 2018 | 2109 | 0.020 |
Why?
|
| Reactive Oxygen Species | 1 | 2014 | 493 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2014 | 1126 | 0.020 |
Why?
|
| Oxidative Stress | 1 | 2014 | 756 | 0.020 |
Why?
|
| Energy Metabolism | 1 | 2014 | 761 | 0.020 |
Why?
|
| Cell Line | 1 | 2014 | 2560 | 0.020 |
Why?
|
| Rats | 1 | 2014 | 3390 | 0.020 |
Why?
|
| Cryptosporidium | 1 | 2007 | 27 | 0.020 |
Why?
|
| Water | 1 | 2007 | 186 | 0.020 |
Why?
|
| Urban Population | 1 | 2007 | 236 | 0.020 |
Why?
|
| Rural Population | 1 | 2007 | 246 | 0.010 |
Why?
|
| Feces | 1 | 2008 | 702 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2014 | 4429 | 0.010 |
Why?
|
| Infant, Premature | 1 | 2008 | 826 | 0.010 |
Why?
|
| Genotype | 1 | 2008 | 2595 | 0.010 |
Why?
|
| Animals | 2 | 2014 | 33051 | 0.010 |
Why?
|
| Risk Factors | 1 | 2007 | 10555 | 0.010 |
Why?
|